Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neerav N Shukla

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Oncology Reports|August 12, 2006
Non-Hodgkin's lymphoma in children and adolescentsNeerav N Shukla, Tanya M Trippett
European Journal of Medical Genetics|January 4, 2024
Therapeutic targeting in pediatric acute myeloid leukemia with aberrant HOX/MEIS1 expressionKristian L Juul-Dam, Neerav N Shukla, Todd M Cooper, et al.
Pediatric Blood & Cancer|October 19, 2018
Maintenance chemotherapy to reduce the risk of a metachronous Wilms tumor in children with bilateral nephroblastomatosisMichael V Ortiz, Shannon Fernandez-Ledon, Kavitha Ramaswamy, et al.
Pediatric Blood & Cancer|July 28, 2017
Novel activating BRAF fusion identifies a recurrent alternative mechanism for ERK activation in pediatric Langerhans cell histiocytosisSara Zarnegar, Benjamin H Durham, Pallavi Khattar, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 7, 2025
Low-Grade Fibro-Osseous Lesions With Isolated Chromosome 12 Chromothripsis: A Distinct Entity Or a Low-Grade Central Osteosarcoma With a Novel Driver?Carla Saoud, Yanming Zhang, Jamal Benhamida, et al.
Transplantation and Cellular Therapy|December 1, 2021
Impact of Bridging Chemotherapy on Clinical Outcomes of CD19-Specific CAR T Cell Therapy in Children/Young Adults with Relapsed/Refractory B Cell Acute Lymphoblastic LeukemiaSanam Shahid, Kavitha Ramaswamy, Jessica Flynn, et al.
Blood Advances|June 18, 2026
Outcomes of Adolescents and Young Adults with AML Treated on Pediatric vs Adult ProtocolsBaher Krayem, Jeetayu Biswas, Andriy Derkach, et al.
JCO Precision Oncology|April 10, 2018
Plasma DNA-based molecular diagnosis, prognostication, and monitoring of patients with <i>EWSR1</i> fusion-positive sarcomasNeerav N Shukla, Juber A Patel, Heather Magnan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2025
Improving global access to genomic profiling in rare pediatric cancersSameer Farouk Sait, Tara J O'Donohue, Tejus Bale, et al.
Cancer Discovery|March 17, 2019
Patient-Driven Discovery, Therapeutic Targeting, and Post-Clinical Validation of a Novel <i>AKT1</i> Fusion-Driven CancerEmily K Slotkin, Daniel Diolaiti, Neerav N Shukla, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Oncology Reports|August 12, 2006
Non-Hodgkin's lymphoma in children and adolescentsNeerav N Shukla, Tanya M Trippett
European Journal of Medical Genetics|January 4, 2024
Therapeutic targeting in pediatric acute myeloid leukemia with aberrant HOX/MEIS1 expressionKristian L Juul-Dam, Neerav N Shukla, Todd M Cooper, et al.
Pediatric Blood & Cancer|October 19, 2018
Maintenance chemotherapy to reduce the risk of a metachronous Wilms tumor in children with bilateral nephroblastomatosisMichael V Ortiz, Shannon Fernandez-Ledon, Kavitha Ramaswamy, et al.
Pediatric Blood & Cancer|July 28, 2017
Novel activating BRAF fusion identifies a recurrent alternative mechanism for ERK activation in pediatric Langerhans cell histiocytosisSara Zarnegar, Benjamin H Durham, Pallavi Khattar, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 7, 2025
Low-Grade Fibro-Osseous Lesions With Isolated Chromosome 12 Chromothripsis: A Distinct Entity Or a Low-Grade Central Osteosarcoma With a Novel Driver?Carla Saoud, Yanming Zhang, Jamal Benhamida, et al.
Transplantation and Cellular Therapy|December 1, 2021
Impact of Bridging Chemotherapy on Clinical Outcomes of CD19-Specific CAR T Cell Therapy in Children/Young Adults with Relapsed/Refractory B Cell Acute Lymphoblastic LeukemiaSanam Shahid, Kavitha Ramaswamy, Jessica Flynn, et al.
Blood Advances|June 18, 2026
Outcomes of Adolescents and Young Adults with AML Treated on Pediatric vs Adult ProtocolsBaher Krayem, Jeetayu Biswas, Andriy Derkach, et al.
JCO Precision Oncology|April 10, 2018
Plasma DNA-based molecular diagnosis, prognostication, and monitoring of patients with <i>EWSR1</i> fusion-positive sarcomasNeerav N Shukla, Juber A Patel, Heather Magnan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2025
Improving global access to genomic profiling in rare pediatric cancersSameer Farouk Sait, Tara J O'Donohue, Tejus Bale, et al.
Cancer Discovery|March 17, 2019
Patient-Driven Discovery, Therapeutic Targeting, and Post-Clinical Validation of a Novel <i>AKT1</i> Fusion-Driven CancerEmily K Slotkin, Daniel Diolaiti, Neerav N Shukla, et al.
Pageof 2